By PA Veterinary Medical Association (PAVMA)
The U.S. Food & Drug Administration (FDA) released their third update on June 27, 2019 regarding the investigation that feeding dogs "grain-free" food increases heart-related issues.
By CPC Scientific Inc.
to develop and manufacture a specific NCE for an undisclosed European biopharmaceutical partner
By CBD Training Academy
The Legal CBD Market is the biggest new opportunity of the decade. FDA meets to set guidelines for the CBD Industry, estimated at $22 billion.
A cloud-based, deep learning software platform can aid healthcare professionals in detecting over 15 types of cardiac arrhythmias using ambulatory ECG monitoring recordings.
The U.S. Food and Drug Administration (FDA) has approved a multi-regional pilot studying the use of blockchain-enabled data technology to track and verify specialty prescription drugs, to ensure safety, enhance value and improve health outcomes.
By Biostar Technology International, LLC
FDA wrongly accused the company Biostar Technology International LLC of marketing natural supplements as cancer drugs.
The Food and Drug Administration (FDA) announced that it has begun the process to make changes to its policy of releasing the names of retailers where products affected by food recalls due to outbreaks that could result in illness or deaths have been...
By My Life Among The Cannibals
On August 22, 2018, the FDA approved the use of 'magic mushrooms', just four days before the release of the new hit single 'I Ate A Mushroom' by Austin, TX based band - My Life Among The Cannibals.
Edupliance announces a webinar titled, "Effective Tools for Drafting Legally Defensible IEP's" attendees will understand how to avoid FDA and FTC warning letter. She will also discuss competitive challenges and how to handle them.
SMi Group Reports: Following the FDA's release of a Biosimilar Action Plan, this year's Biosimilars USA conference promises to explore the developments in biosimilar drug development
By Nova Biomedical
Nova Biomedical has been awarded a new multi-year group purchasing agreement for glucose meters from Premier.
By Pharmaceutical Investing News
According to our sources, Intellipharmaceutics International Inc. (IPCI) will be announcing an International partnership with a Chinese pharmaceutical company soon.
By SMi Group
SMi Group reports: Last call for registrations to Pre-Filled Syringes East Coast conference
By American Conference Institute
American Conference Institute (ACI) is pleased to announce that it will once again collaborate with Council for Responsible Nutrition (CRN) on ACI's Legal, Regulatory and Compliance Forum on Dietary Supplements taking place in New York City at the...
By SMi Group
SMi Group reports: Doors open to the 5th annual Pre-Filled Syringes East Coast conference and exhibition in just few weeks' time (April 11-12, Boston) and attendee list has been released.
By MaxLabs US, LLC
MaxLabs US, the Michigan-based producer of IMPRESS! Dietary Supplement for Men, reveals study results showing a previously-unidentified link among FDA-recalled men's supplements- 100% of the studied products' UPC codes aren't assigned to the entities...
By American Council on Science and Health
ACSH testified before the FDA TPSAC on the MRTPA submitted by PMI for their IQOS system
By SMi Group
SMi Group has announced that Mr John Carlsen, Vice President at Covance, has joined the speaker line-up for the 4th annual Biosimilars North America conference which takes place on November 15 & 16 in New Jersey.